Schedule of Restricted Stock Award Activity (Details) - $ / shares		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021
2014 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested restricted stock, shares		100,000		100,000
Restricted Stock Units (RSUs) [Member] | 2014 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		1,666,666	[1]	1,416,666
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance		$ 2.36	[1]	$ 1.72
Number of Stock Options, Granted				400,000
Weighted Average Grant Date Fair Value, Granted				$ 4.50
Number of Stock Options, Vested		(541,666)		(150,000)
Weighted Average Grant Date Fair Value, Vested		$ 1.20		$ 2.04
Number of Stock Options, Forfeited		(150,000)
Weighted Average Grant Date Fair Value, Forfeited		$ 2.04
Number of Stock Options Outstanding, Ending Balance	[1]	975,000		1,666,666
Weighted Average Grant Date Fair Value, Outstanding, Ending Balance	[1]	$ 3.05		$ 2.36
Restricted Stock Units (RSUs) [Member] | 2018 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		1,940,740	[2]
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance		$ 12.76	[2]
Number of Stock Options, Granted		320,000		1,947,795
Weighted Average Grant Date Fair Value, Granted		$ 4.53		$ 12.76
Number of Stock Options, Vested		(169,320)
Weighted Average Grant Date Fair Value, Vested		$ 13.48
Number of Stock Options, Forfeited				(7,055)
Weighted Average Grant Date Fair Value, Forfeited				$ 13.11
Number of Stock Options Outstanding, Ending Balance	[2]	2,091,420		1,940,740
Weighted Average Grant Date Fair Value, Outstanding, Ending Balance	[2]	$ 11.44		$ 12.76

[1] The unvested restricted stock awards presented in the table above, are inclusive of 100,000 restricted stock awards granted outside the PAVmed Inc. 2014 Equity Plan as of December 31, 2022 and December 31, 2021.

[2] The unvested restricted stock awards presented in the table above, are inclusive of 50,000 restricted stock awards granted outside the Lucid Diagnostics Inc. 2018 Equity Plan as of December 31, 2022 and December 31, 2021.